Glucose Tolerance and the Risk Factors for Transmission in Japanese SARS-CoV-2/WA-1/2020 Epicenter: A Retrospective Study

References

• Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323(14):1406–1407. doi:10.1001/jama.2020.2565
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Novel coronavirus – Thailand (ex-China). Who.int. Available from: https://www.who.int/csr/don/14-january-2020-novel-coronavirus-thailand/en/. Accessed January 19, 2020.
   Google Scholar
• First travel-related case of 2019 novel coronavirus detected in United States. Centers for Disease Control and Prevention; 2020. Available from: https://www.cdc.gov/media/releases/2020/p0121-novel-coronavirus-travel-case.html. Accessed January 23, 2020.
   Google Scholar
• Merchant HA, Kow CS, Hasan SS. COVID-19 first anniversary review of cases, hospitalization, and mortality in the UK. Expert Rev Respir Med. 2021;15:973–978. doi:10.1080/17476348.2021.1890035
   PubMed Web of Science ®Google Scholar
• Wang H, Paulson KR, Pease SA; COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19- related mortality, 2020–21. Lancet. 2022;399:1513–1536. doi:10.1016/S0140-6736(21)02796-3
   PubMed Web of Science ®Google Scholar
• de Lusignan S, Dorward J, Correa A, et al. Risk factors for SARS-CoV-2 among patients in the oxford royal college of general practitioners research and surveillance centre primary care network: a cross-sectional study. Lancet Infect Dis. 2020;20:1034–1042. doi:10.1016/S1473-3099(20)30371-6
   PubMed Web of Science ®Google Scholar
• Subramanian A, Nirantharakumar K, Hughes S, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28:1706–1714. doi:10.1038/s41591-022-01909-w
   PubMed Web of Science ®Google Scholar
• Holman N, Knighton P, Kar P, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8:823–833. doi:10.1016/S2213-8587(20)30271-0
   PubMed Web of Science ®Google Scholar
• Mahamat-Saleh Y, Fiolet T, Rebeaud ME, et al. Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies. BMJ. 2021;11:e052777. doi:10.1136/bmjopen-2021-052777
   PubMed Web of Science ®Google Scholar
• Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16):1574–1581. doi:10.1001/jama.2020.5394
   PubMed Web of Science ®Google Scholar
• Zhu L, She ZG, Cheng X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing Type 2 diabetes. Cell Metab. 2020;31:1068–1077.e3. doi:10.1016/j.cmet.2020.04.021
   PubMed Web of Science ®Google Scholar
• Wang S, Ma P, Zhang S, et al. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study. Diabetologia. 2020;63:2102–2111. doi:10.1007/s00125-020-05209-1
   PubMed Web of Science ®Google Scholar
• Madruga MP, Grun LK, Santos LSMD, et al. Excess of body weight is associated with accelerated T-cell senescence in hospitalized COVID-19 patients. Immun Ageing. 2024;21(1):17. PMID: 38454515; PMCID: PMC10921685. doi:10.1186/s12979-024-00423-6
   PubMed Web of Science ®Google Scholar
• Wu J, Huang J, Zhu G, et al. Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study. BMJ Open Diabetes Res Care. 2020;8:e001476. doi:10.1136/bmjdrc-2020-001476
   PubMed Web of Science ®Google Scholar
• Bar-Or D, Rael LT, Madayag RM, et al. Stress hyperglycemia in critically ill patients: insight into possible molecular pathways. Front Med. 2019;6:54. doi:10.3389/fmed.2019.00054
   Web of Science ®Google Scholar
• Coppelli A, Giannarelli R, Aragona M, et al. Hyperglycemia at hospital admission is associated with severity of the prognosis in patients hospitalized for COVID-19: the Pisa COVID-19 study. Diabetes Care. 2020;43:2345–2348. doi:10.2337/dc20-1380
   PubMed Web of Science ®Google Scholar
• Ilyas R, Wallis R, Soilleux EJ, et al. High glucose disrupts oligosaccharide recognition function via competitive inhibition: a potential mechanism for immune dysregulation in diabetes mellitus. Immunobiology. 2011;216:126–131. doi:10.1016/j.imbio.2010.06.002
   PubMed Web of Science ®Google Scholar
• Rakhmat II, Kusmala YY, Handayani DR, et al. Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19) – a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2021;15:777–782. doi:10.1016/j.dsx.2021.03.027
   PubMed Web of Science ®Google Scholar
• Li J, Wang X, Chen J, Zuo X, Zhang H, Deng A. COVID-19 infection may cause ketosis and ketoacidosis. Diabetes Obes Metab. 2020;22:1935–1941. doi:10.1111/dom.14057
   PubMed Web of Science ®Google Scholar
• Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, Cook DG. Glycemic control and risk of infections among people with Type 1 or Type 2 diabetes in a large primary care cohort study. Diabetes Care. 2018;41:2127–2135. doi:10.2337/dc18-0287
   PubMed Web of Science ®Google Scholar
• American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–S38. doi:10.2337/dc22-S002
   PubMedGoogle Scholar
• Li F, Li YY, Liu MJ, et al. Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study. Lancet Infect Dis. 2021;21:617–628. doi:10.1016/S1473-3099(20)30981-6
   PubMed Web of Science ®Google Scholar
• Cowling BJ, Fang VJ, Suntarattiwong P, et al. Aerosol transmission is an important mode of influenza A virus spread. Nat Commun. 2013;4:1935. doi:10.1038/ncomms2922
   PubMed Web of Science ®Google Scholar
• Wang CC, Prather KA, Sznitman J, et al. Airborne transmission of respiratory viruses. Science. 2021;373:eabd9149. doi:10.1126/science.abd9149
   PubMed Web of Science ®Google Scholar
• Cheng HY, Jian SW, Liu DP, et al. Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset. JAMA Intern Med. 2020;180:1156–1163. doi:10.1001/jamainternmed.2020.2020
   PubMed Web of Science ®Google Scholar
• Burke RM, Midgley CM, Dratch A, et al. Active monitoring of persons exposed to patients with confirmed COVID-19 – United States, January–February 2020. MMWR Morb Mortal Wkly Rep. 2020;69:245–246. doi:10.15585/mmwr.mm6909e1
   PubMed Web of Science ®Google Scholar
• J appendices. Cdc.gov. Available from: https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/contact-tracing-plan/appendix. Accessed May 17, 2021.
   Google Scholar
• Jarvis CI, Van Zandvoort K, Gimma A, Prem K; CMMID COVID-19 working group. Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK. BMC Med. 2020;18:124. doi:10.1186/s12916-020-01597-8
   PubMed Web of Science ®Google Scholar
• Qin R, He L, Yang Z, et al. Identification of parameters representative of immune dysfunction in patients with severe and fatal COVID-19 infection: a systematic review and meta-analysis. Clin Rev Allergy Immunol. 2023;64:33–65. doi:10.1007/s12016-021-08908-8
   PubMed Web of Science ®Google Scholar
• Chen Z, Li J, Zheng J, et al. Characteristics of lymphocyte subsets and inflammatory factors in patients with COVID-19. Heliyon. 2024;10(6):e28451. PMID: 38545136; PMCID: PMC10966702. doi:10.1016/j.heliyon.2024.e28451
   PubMed Web of Science ®Google Scholar
• Tudoran C, Tudoran M, Cut TG, et al. The impact of metabolic syndrome and obesity on the evolution of diastolic dysfunction in apparently healthy patients suffering from post-COVID-19 syndrome. Biomedicines. 2022;10(7):1519. PMID: 35884823; PMCID: PMC9312435. doi:10.3390/biomedicines10071519
   PubMed Web of Science ®Google Scholar
• Gao M, Piernas C, Astbury NM, et al. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021;9(6):350–359. PMID: 33932335; PMCID: PMC8081400. doi:10.1016/S2213-8587(21)00089-9
   PubMed Web of Science ®Google Scholar